Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(68 sites)

United States

USA010, Los Angeles, California

USA001, Santa Barbara, California

USA006, Naples, Florida

USA003, Bend, Oregon

USA013, Philadelphia, Pennsylvania